0.8524
price down icon4.54%   -0.0405
after-market Handel nachbörslich: .84 -0.0124 -1.45%
loading

Finanzdaten der Tenaya Therapeutics Inc-Aktie (TNYA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
13.06%
20.94
24.08 27.54 24.65 26.71
Depreciation and Amortization
9.52%
1.90
2.10 2.70 2.10 2.10
Operating Income/Loss
13.06%
-20.94
-24.08 -27.54 -24.65 -26.71
Nonoperating Income/Loss
17.27%
0.661
0.799 0.674 0.816 1.077
Income/Loss From Continuing Operations Before Tax
12.92%
-20.27
-23.28 -26.86 -23.84 -25.63
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
12.92%
-20.27
-23.28 -26.86 -23.84 -25.63
Net Income/Loss
12.92%
-20.27
-23.28 -26.86 -23.84 -25.63
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.34%
163.35
162.79 109.87 0.5317 86.16
Diluted Average Shares
0.34%
163.35
162.79 109.87 0.5317 86.16
Basic Earnings Per Share
14.29%
-0.12
-0.14 -0.24 -0.27 -0.30
Diluted Earnings Per Share
14.29%
-0.12
-0.14 -0.24 -0.27 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):